Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.120
-0.020 (-1.75%)
At close: May 14, 2025, 4:00 PM
1.120
0.00 (0.00%)
After-hours: May 14, 2025, 4:00 PM EDT
Marker Therapeutics Stock Forecast
MRKR's stock price has decreased by -72.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Marker Therapeutics stock ranges from a low of $8.00 to a high of $19. The average analyst price target of $13.17 forecasts a 1,075.89% increase in the stock price over the next year.
Price Target: $13.17 (+1,075.89%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 1, 2025.
Analyst Ratings
The average analyst rating for Marker Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| WBB Securities | WBB Securities | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +1,016.07% | Apr 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +614.29% | Mar 5, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +1,596.43% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +882.14% | Apr 30, 2024 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $30 → $10 | Strong Buy → Hold | Downgrades | $30 → $10 | +792.86% | Feb 17, 2022 |
Financial Forecast
Revenue This Year
3.29M
from 6.59M
Decreased by -50.11%
Revenue Next Year
1.97M
from 3.29M
Decreased by -40.18%
EPS This Year
-2.68
from -1.19
EPS Next Year
-2.89
from -2.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.1M | 6.1M | 34.5M | ||
| Avg | 3.3M | 2.0M | 24.2M | ||
| Low | n/a | n/a | 14.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -7.8% | 84.7% | 1,653.9% | ||
| Avg | -50.1% | -40.2% | 1,128.1% | ||
| Low | - | - | 656.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.35 | -0.80 | -0.29 | ||
| Avg | -2.68 | -2.89 | -1.32 | ||
| Low | -4.27 | -5.05 | -2.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.